You may be trying to access this site from a secured browser on the server. Please enable scripts and reload this page.
American Association for Clinical Chemistry
Better health through laboratory medicine
Home
|
Customer Service
|
Site Map
|
Cart
|
Login
About AACC
Members
Events
Government & Public Affairs
Resource Centers
Professional Development
Publications
AACC Store
>
Members
>
NACB - The AACC Academy
>
NACB Blog
Recent Posts
Should We Still be Performing Fetal Fibronectin Testing in the Clinical Lab?
What is the diagnosis?
Newborn Screening for Severe Combined Immunodeficiency (SCID): Should it be performed?
Are reference change values more useful than population-based reference intervals?
Categories
Cancer and Tumor Markers
Case Study
Clinical Translational Science/Proteomics
CVD/Markers/Risk Factors
Diabetes/Endocrinology
Government Affairs/Patient Safety
Immunology/Infectious Disease
Instrumentation/Technology
Management/Medical Informatics
Molecular Pathology and Genetics
New/Other Disease Markers
Nutrition
POC Testing
Renal/GI/Hepatic
Special Populations
TDM/Toxicology
Archives
Year
: 2013
June 2013
May 2013
April 2013
March 2013
February 2013
January 2013
Year
: 2012
December 2012
November 2012
October 2012
September 2012
August 2012
July 2012
June 2012
May 2012
April 2012
March 2012
February 2012
January 2012
Year
: 2011
December 2011
November 2011
October 2011
September 2011
August 2011
July 2011
June 2011
May 2011
April 2011
March 2011
February 2011
January 2011
RSS Feed
NACB Blog
Procalcitonin: The Answer to the Sepsis Dilemma?
3/29/2011 8:01 AM |
Comments (6)
Recommend (1,909)
By
Alison Woodworth, PhD, DABCC, FACB
Sepsis is systemic inflammation due to infection. It is the most common cause of death in intensive care units (1), with a mortality rate up to 50% depending on severity. Sepsis can be considered in individuals with systemic inflammatory response syndrome (SIRS) manifested by alterations in at le...(
Read More
)
Posted at 3/29/2011 8:01 AM | Tags:
New/Other Disease Markers
|
Immunology/Infectious Disease
Does POCT Creatinine Meet Performance Expectations?
3/22/2011 8:08 AM |
Comments (4)
Recommend (1,659)
By
James H. Nichols, PhD, DABCC, FACB
The need for rapid estimates of renal function is leading to greater demand for point-of-care creatinine testing in a variety of patient settings including Radiology, to determine patient ability to clear contrast dyes, and Hematology/Oncology, for dosing chemotherapeutic agents. This demand h...(
Read More
)
Posted at 3/22/2011 8:08 AM | Tags:
Renal/GI/Hepatic
|
POC Testing
Neonatal Bilirubin: Nomograms, Fractions, and Transcutaneous Measurements
3/15/2011 8:06 AM |
Comments (4)
Recommend (1,654)
By
Stanley F. Lo, PhD, DABCC, FACB
Why do we measure bilirubin in neonates? As most of you know, the natural physiological process of neonatal jaundice can be harmful to the newborn if the bilirubin concentration is too high. In the case of neonatal hyperbilirubinemia, the increase is primarily due to an immature liver which is ...(
Read More
)
Posted at 3/15/2011 8:06 AM | Tags:
Renal/GI/Hepatic
|
Special Populations
K2: Second Highest Mountain in the World or Another Type of High?
3/8/2011 8:05 AM |
Comments (2)
Recommend (1,108)
By
Donald L. Frederick, PhD, DABFT, FACB
Although K2 has been known since 1856 as the second highest mountain (to Everest) in the Karakorum Range, more recently K2 has been known for another type of high; the high that is achieved by smoking synthetic cannabinoids. Although the origin of these compounds can be traced to synthetic pr...(
Read More
)
Posted at 3/8/2011 8:05 AM | Tags:
TDM/Toxicology
1 - 4
(Hidden) Admin Links
About AACC
|
Members
|
Government & Public Affairs
|
Resource Centers
|
Professional Development
|
Publications
Home
|
Customer Service
|
Site Map
|
AACC Store
|
Login
Contact Us
|
Privacy Policy and Legal Disclaimer
|
Join AACC
©2013 American Association for Clinical Chemistry
1850 K Street, NW Suite 625
Washington, DC 20006
Phone: (800) 892-1400 | Fax: (202) 887-5093